Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
About
Pricing
Company Reports
Kedrion
Kedrion
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
No data
Company Revenue
No data
Revenue by Drug
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
Kedbumin
Albumin human
2011-06-03
—
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Human immunoglobulin g
agammaglobulinemia
,
primary immunodeficiency diseases
,
autoimmune diseases
,
chronic inflammatory demyelinating polyradiculoneuropathy
,
hematologic diseases
,
blood coagulation disorders
,
thrombocytopenic purpura idiopathic
,
hemorrhagic disorders
,
nervous system diseases
,
stiff-person syndrome
Lambda-cyhalothrin
hemophilia a
,
hemophilia b
,
hematologic diseases
,
inborn genetic diseases
,
blood coagulation disorders
,
hemorrhagic disorders
,
coagulation protein disorders
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) |
Terms of Use